The more the merrier: Faecalibacterium prausnitzii in Crohn's disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 28, Issue 5, 2013, Pages 757-759

  O'Brien, Claire L ^a,b   Allison, Gwen E ^b,c   Pavli, Paul ^a,c  

^a CANBERRA HOSPITAL   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^c The Australian National University   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTEROIDETES; BILOPHILA WADSWORTHIA; CROHN DISEASE; DISEASE ACTIVITY; EDITORIAL; ENTEROBACTERIACEAE; EUBACTERIUM; FAECALIBACTERIUM PRAUSNITZII; FIRMICUTES; HUMAN; INTESTINE FLORA; MICROBIAL DIVERSITY; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 84876972671     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/jgh.12153     Document Type: Editorial

References (15)

1. De Hertogh G, Aerssens J, Geboes KP, Geboes K. Evidence for the involvement of infectious agents in the pathogenesis of Crohn's disease. World J. Gastroenterol. 2008; 14: 845-852.
2. Sokol H, Pigneur B, Watterlot L etal. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl Acad. Sci. U. S. A. 2008; 105: 16731-16736.
3. Wang RF, Cao WW, Cerniglia CE. Phylogenetic analysis of Fusobacterium prausnitzii based upon the 16S rRNA gene sequence and PCR confirmation. Int. J. Syst. Bacteriol. 1996; 46: 341-343.
4. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment. Pharmacol. Ther. 2008; 27: 104-119.
5. Fujimoto T, Imaeda H, Takahashi K etal. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J. Gastroenterol. Hepatol. 2013; 28: 613-619.
6. Devkota S, Wang Y, Musch MW etal. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature 2012; 487: 104-108.
7. De Filippo C, Cavalieri D, Di Paola M etal. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl Acad. Sci. U. S. A. 2010; 107: 14691-14696.
8. Inoue N, Tamura K, Kinouchi Y etal. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 86-91.
9. Nakagome S, Takeyama Y, Mano S etal. Population-specific susceptibility to Crohn's disease and ulcerative colitis; dominant and recessive relative risks in the Japanese population. Ann. Hum. Genet. 2010; 74: 126-136.
10. Joossens M, Huys G, Cnockaert M etal. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011; 60: 631-637.
11. Willing B, Halfvarson J, Dicksved J etal. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm. Bowel Dis. 2009; 15: 653-660.
12. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl Acad. Sci. U. S. A. 2011; 108 (Suppl. 1): 4554-4561.
13. Swidsinski A, Loening-Baucke V, Vaneechoutte M, Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm. Bowel Dis. 2008; 14: 147-161.
14. Sokol H, Seksik P, Furet JP etal. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 2009; 15: 1183-1189.
15. Jia W, Whitehead RN, Griffiths L etal. Is the abundance of Faecalibacterium prausnitzii relevant to Crohn's disease? FEMS Microbiol. Ecol. 2010; 310: 138-144.